Zobrazeno 1 - 10
of 25
pro vyhledávání: '"11"'
Publikováno v:
Annals of Oncology. 26:iii4
Autor:
F-C Bidard, Y. De Rycke, Delphine Loirat, Xavier Sastre-Garau, Leonor Chaltiel, Anne Vincent-Salomon, J-Y Pierga, Y.M. Kirova, Frédérique Berger, Véronique Diéras, Paul-Henri Cottu, Séverine Alran
Publikováno v:
Annals of Oncology. 25:iv118
Aim: BM DTC detection is known to be a prognostic factor for distant metastasis and overall survival in early breast cancer. However, distant relapses may occur in patients with no DTC detected at time of primary cancer. In this study, we studied the
Autor:
Giordano B. Chiara, Stefano M.M. Basso, Davide Adriano Santeufemia, Giovanni Lo Re, Franco Lumachi, Filippo Marino
Publikováno v:
Annals of Oncology. 24:iv110
Background: Colorectal cancer (CRC) is a common cancer that in 25-30% of cases develops recurrence in the absence of positive regional lymph nodes. CRC is the second leading cause of cancer-related deaths in the USA. According to the AJCC the 5-year
Publikováno v:
Annals of Oncology. 30:v50-v51
Background Dysregulation of various miRNAs has been linked to the initiation and progression of several cancers including acute myeloid leukemia (AML). However, their role in pediatric cytogenetically normal AML (CN-AML) is still unclear. The objecti
Publikováno v:
Annals of Oncology. 30:ix38
Background In present time, neoadjuvant chemoradiotherapy for distal rectal cancer is part of clinical guidelines in Europe and the USA. According to the literature, there are no unified standards for upper rectal cancer. Methods The study included d
Publikováno v:
Annals of Oncology. 30:vii11
Background Although p53 pathway was previously explored in human carcinogenesis, the clinical implication of this gene is still unknown. The aim of this paper was to explore the particularities of TP53gene, at molecular and protein level, in gastric
Publikováno v:
Annals of Oncology. 30:ix37
Background Polyps are considered as obligate precancerous disease. Different authors consider that percent of malignization ranges from 20% in single polyps to 95% in diffuse polyposis. Current research examines the results of the early diagnosis of
Autor:
Steven G. DuBois, A. Drilon, Shivani Nanda, C.M. van Tilburg, Antoine Italiano, Michael Capra, Andrej Lissat, David S. Hong, David S. Ziegler, J.-H. Kang, Birgit Geoerger, Ariadna Holynskyj, David M. Hyman, Valentina Boni, François Doz, Makoto Tahara, Sébastien Perreault, Juneko E. Grilley-Olson, N. Brega
Publikováno v:
Annals of Oncology. 30:ix124
Background TRK fusions are oncogenic drivers of a variety of tumors, many of which can involve the central nervous system (CNS). Larotrectinib is an FDA-approved selective TRK inhibitor for the treatment of TRK fusion cancer (Drilon et al., NEJM 2018
Autor:
Emilio Esteban, M.D. Isla Casado, I.C. Barneto Aranda, Angel Artal-Cortes, Ma.Teresa Alvarez y Muñoz, José Sánchez-Payá, J.M. Sanchez Torres, Jose-Luis Gonzalez-Larriba, M. Provencio, D. Rodriguez Abreu, J. De Castro Carpeno, Rosa Rosell, E. Pereira, M.T. Moran Bueno, B. Massuti Sureda, L. Iglesias, G. López Vivanco, M. Cobo Dols, R. López, R. de las Penas Bataller
Publikováno v:
Annals of Oncology. 30:v585
Background Post-operative platinum-based chemotherapy is the standard of care for resected NSCLC with nodal involvement. Expression of genes involved in DNA repair may have a prognostic role for the outcome. BRCA1 plays an important role in DNA repai
Autor:
Takesumi Ozawa, Takuro Noguchi, Tomonobu Koizumi, Shun'ichiro Taniguchi, Takashi Kobayashi, Nodoka Sekiguchi, Toshiro Fukushima, Mariko Miyagawa, Daisuke Gomi
Publikováno v:
Annals of Oncology. 30:vi112
Liquid biopsy using blood is the next-generation technology in the field of cancer diagnosis. Since the proportion of circulating tumor DNA (ctDNA) in the total cell-free DNA (cfDNA) can be extremely low, it is important to use as much cfDNA input as